News Spark files revolutionary gene therapy with FDA Luxturna granted six-month priority review by FDA.
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News Amicus to file Fabry drug after FDA changes mind Regulator drops demand for further phase 3 trial.
News The curious case of Mylotarg: Pfizer's leukaemia drug set to... Mylotarg backed by advisers after withdrawal in 2010.
Events Partner Content Clinical Trial Supply East Coast 2017 The 15th Annual CTS East Coast event builds on last year’s conference, Arena’s biggest East Coast CTS event to date.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
